XML 165 R148.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Information (Other Income (Expense), Net) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Supplemental Information [Abstract]              
Technology and royalty income [1]         $ 22.8 $ 20.8 $ 19.0
Interest income [2]         0.0 1.5 6.1
Foreign exchange         (3.9) 4.3 (7.2)
Sale of assets and investments [3]         6.9 24.3 8.8
Contract settlements         2.9 14.3 12.6
Transition service agreements reimbursement [4]         12.7 38.4 0.0
Other         8.8 17.4 10.1
Other income (expense), net         $ 50.2 121.0 $ 49.4
Gain on land sale $ 12.2 $ 0.0 $ 0.0 $ 0.0   $ 12.2  
[1] Primarily includes related party activity with our equity affiliates.
[2] Beginning in the second quarter of fiscal year 2017, interest income associated with our cash and cash items and short-term investments is reflected on the consolidated income statements in "Other non-operating income (expense), net."
[3] Includes a gain of $12.2 resulting from the sale of a parcel of land during the fourth quarter of fiscal year 2017.
[4] Reflects reimbursement for costs in support of transition services agreements with Versum for EMD and with Evonik for PMD. Refer to Note 4, Materials Technologies Separation, for additional information.